["{\n\"step_by_step_thinking\": \"The situation is about a new drug combination of chemotherapy and immunotherapy prescribed for metastatic melanoma. The patient's survival is prolonged, which implies that the treatment has some anti-tumor effect. Since the patient had disseminated malignant melanoma, which usually shows little response to chemotherapy, the addition of immunotherapy might have enhanced the anti-tumor effect. The increased survival rate suggests that the combination therapy may have led to a reduction in the incidence of new metastases and/or an increase in the destruction of existing metastases.\",\n\"answer_choice\": C\n}"]